- April 27, 2016
Five research projects with commercial potential receive sustaining funding through Harvard’s Physical Sciences & Engineering Accelerator.
- August 19, 2015
Twelve advanced research projects aimed at developing new therapies and diagnostics receive support in 2015-16 from Harvard’s Blavatnik Biomedical Accelerator.
Maxwell Dworkin 119
Learn more about technology commercialization and enjoy pizza while networking with other Harvard innovators. As part of our multi-part speaker series, co-founders Yaro Tenzer, PhD, and Leif Jentoft, PhD, will share the story of how they translated their Harvard research into the startup, RightHand Robotics, applying robotic grasping technology to improve material handling.
- March 04, 2015
NEWTON, Mass.--(BUSINESS WIRE)--Macrolide Pharmaceuticals, a new company with groundbreaking technology to develop novel antibiotics, completed a Series A financing of $22 million led by Novartis Venture Fund, Gurnet Point Capital, Roche Ventures, and SROne. The financing follows a worldwide license agreement between Harvard's Office of Technology Development and the company, providing exclusive rights to the technology.
Professor Jennifer Lewis discusses her revolutionary work in 3D printing, her entrepreneurial goals, and what is next on the horizon.
Page 2 of 4